If you think last week's decision by the federal government to halt $500 million in funding for vaccine development projects that use mRNA technology will only affect COVID vaccines, think again.

Alfredo has a PhD in Astrophysics and a Master's in Quantum Fields and Fundamental Forces from Imperial College London.View full profile Alfredo has a PhD in Astrophysics and a Master's in Quantum ...

The success of mRNA technology and its potential uses in therapeutics and preventative medical treatment may create a new technology ecosystem, the Harvard Business Review reported April 18. As has ...

(Nanowerk News) Researchers at The University of Queensland are harnessing the latest sequencing technology developed by UK-based biotech Oxford Nanopore Technologies to analyse mRNA vaccines and ...

A screen at the Karolinska Institute shows this year's laureates Katalin Kariko of Hungary (L) and Drew Weissman of the US during the announcement of the winners of the 2023 Nobel Prize in Physiology ...

Nobel Prizes for 2023 have been announced, and one of them has probably had a profound impact on your life. The institution has awarded the 2023 Prize in Physiology or Medicine to Katalin Karikó and ...

The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase III trial that will test out a vaccine against norovirus, a frequent and ...

An mRNA therapy efficaciously corrected—in a mouse model—altered glutathione metabolism, offering a prospective avenue for treating argininosuccinic aciduria (ASA), an inherited metabolic disorder.

Mycobacterium tuberculosis (Public Health Image Library, NIAID, Image ID: 18139) Mycobacterium tuberculosis (Public Health Image Library, NIAID, Image ID: 18139) Tuberculosis (TB) is the number one ...

COVID vaccine technology could help reduce disabilities in people caused by injuries from snakebites. Researchers at the University of Reading, England, found that the same mRNA tech used in ...

The Biden administration’s new biomedical research agency said Wednesday it is investing up to $24 million to develop mRNA platforms that can train the immune system to more effectively fight cancer ...